グリクラジドの中国市場

調査会社China Research and Intelligence社が発行したリサーチレポート(データ管理コード:DATA8102365)
◆英語タイトル:Investigation Report on China's Gliclazide Market, 2018-2022
◆発行会社/調査会社:China Research and Intelligence
◆商品コード:DATA8102365
◆発行日:2018年9月
◆調査対象地域:中国
◆産業分野:製薬
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,200 ⇒換算¥239,800見積依頼/購入/質問フォーム
EnterprisewideUSD3,300 ⇒換算¥359,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
China Research and Intelligence社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[グリクラジドの中国市場]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DescriptionThe overweight population and the incidence of type 2 diabetes are growing in China as the economy develops, the population ages, and the lifestyle changes. The number of people with type 2 diabetes exceeded 110 million at the end of 2017, and is still rising.
Taken by mouth, Gliclazide is a second-generation sulfonylurea to treat diabetes by stimulating insulin secretion from pancreatic β-cells. It can protect pancreatic β-cells from the apoptosis caused by hyperglycemia, and prevent atherosclerosis (build-up of fatty deposits in the arteries) caused by type 2 diabetes.
Developed by French company Servier, Gliclazide (trade name: Diamicron) was first launched in France in 1972, and entered China in the 1980s. In China, at least 200,000 people with type 2 diabetes are taking Gliclazide every year.
In 1987, Tianjin Huajin Pharmaceutical Factory (now known as Tianjin Huajin Pharmaceutical Co., Ltd.) started cooperating with Servier and Tianjin Pharmaceutical Station to produce Gliclazide (Diamicron), a new drug to treat type 2 diabetes. With the support of Servier, the company has been taking the leading position on China’s Gliclazide market. Also dominating the market are Servier and Servier (Tianjin) Pharmaceutical Co., Ltd., the joint venture of Servier and Tianjin Huajin Pharmaceutical Co., Ltd.
According to CRI, the sales value of Gliclazide kept rising after the drug entered China, and exceeded CNY 200 million in 2017. It is expected that China’s Gliclazide market will continue to grow as the incidence of type 2 diabetes rises.

*** レポート目次(コンテンツ)***

Table of Contents
1 Relevant Concepts of Gliclazide
1.1 Indications for Gliclazide
1.2 Development History of Gliclazide in China
1.3 Governmental Approval of Gliclazide in China

2 Sales of Gliclazide in China, 2013-2017
2.1 Sales Value
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Gliclazide by Dosage Form in China, 2013-2017
2.3.1 Tablets
2.3.2 Capsules

3 Analysis on Major Gliclazide Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Gliclazide Manufacturers
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Servier
3.2.1 Enterprise Profile
3.2.2 Sales of Servier’s Gliclazide in China
3.3 Servier (Tianjin) Pharmaceutical Co., Ltd.
3.4 Tianjin Huajin Pharmaceutical Co. Ltd.
3.5 Nanchang Helioeast Pharmaceutical Co., Ltd.
3.6 Guilin Hwasun Pharmaceutical Co., Ltd.

4 Prices of Gliclazide in China, 2017-2018
4.1 Servier (Diamicron)
4.2 Servier (Tianjin) Pharmaceutical Co., Ltd. (Diamicron)
4.3 Tianjin Huajin Pharmaceutical Co. Ltd. (Diamicron)
4.4 Nanchang Helioeast Pharmaceutical Co., Ltd. (Hongxuyang)
4.5 Guilin Hwasun Pharmaceutical Co., Ltd. (Xieerping)

5 Prospect of China’s Gliclazide Market, 2018-2022
5.1 Forecast on Market Size
5.2 Forecast on Market Trend

Selected Charts
Chart Sales of Gliclazide in China, 2013-2017
Chart Sales Value of Gliclazide in Parts of China, 2013-2017
Chart Sales Volume of Gliclazide in China, 2013-2017
Chart Sales Value of Gliclazide Tablets in China, 2013-2017
Chart Sales Value of Gliclazide Capsules in China, 2013-2017
Chart Market Share of Top 5 Gliclazide Manufacturers by Sales Value in China, 2013-2017
Chart Profile of Servier
Chart Sales Value of Servier’s Gliclazide in China, 2013-2017
Chart Sales Value of Servier (Tianjin) Pharmaceutical Co., Ltd.’s Gliclazide in China, 2013-2017
Chart Sales Value of Servier Tianjin Huajin Pharmaceutical Co. Ltd.’s Gliclazide in China, 2013-2017
Chart Prices of Servier’s Gliclazide in Parts of China, 2017-2018
Chart Prices of Servier (Tianjin) Pharmaceutical Co., Ltd.’s Gliclazide in Parts of China, 2017-2018
Chart Prices of Tianjin Huajin Pharmaceutical Co. Ltd.’s Gliclazide in Parts of China, 2017-2018
Chart Governmental Approval of Gliclazide in China
Chart Forecast on Sales Value of Gliclazide in China, 2018-2012



*** レポートのキーワード ***

グリクラジド

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 紙巻たばこ(シガレット)市場:コスタリカ
    Synopsis World Cigarettes Costa Rica focuses on the extent to which the market has evolved during the last twelve years in line with changing smoking habits in Costa Rica, the competitive environment and economic developments. The end result is an accurate and objective interpretation of market tren …
  • 塩化カリウムの世界市場2015
    The Global Potassium Chloride Industry Report 2015 is a professional and in-depth study on the current state of the Potassium Chloride industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Potassium Chlor …
  • Xバンドレーダーの世界市場2017-2026
    According to Stratistics MRC, the X-Band Radar market is accounted for $4.76 billion in 2017 and is expected to reach $7.65 billion by 2026 growing at a CAGR of 5.4%. Increasing security concerns, growing use of the X-band radar in defense and increase in use of radar systems for digital signal proc …
  • 溶剤型包装印刷の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Solvent-based Packaging Printing Revenue, means the sales value of Solvent-based Packaging Printing This report studies sales (consumption) of Solvent-based Packaging Printing in Global market, especially in United States, China, Europe and Japan, focuses on to …
  • プラント資産管理(PAM)の世界市場予測:生産資産、オートメーション資産
    The plant asset management (PAM) market is expected to be valued at USD 7.87 Billion by 2022, at a CAGR of 10.7% between 2016 and 2022. The growth of this market is propelled by increasing adoption of lean manufacturing practices and growing demand for cloud-based plant asset management solutions, r …
  • 乳児用おもちゃの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Infant Toys Revenue, means the sales value of Infant Toys This report studies sales (consumption) of Infant Toys in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenu …
  • ホウ酸塩鉱物の世界市場予測2018-2023
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Borate Mineral market for 2018-2023. Borate Mineral is a compound in which a metal element cation is combined with a borate. It is mainly white, colorless or light, transpare …
  • CREATIVE TOURS PTY LIMITED – 企業概要
    WMI's 'CREATIVE TOURS PTY LIMITED - Company Capsule' is a crucial resource for industry executives and anyone looking to access key information about 'CREATIVE TOURS PTY LIMITED'. WMI's 'CREATIVE TOURS PTY LIMITED - Company Capsule' report utilizes a wide range of primary and secondary sources, whic …
  • China Sky One Medical, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' China Sky One Medical, Inc. Mer …
  • スポーツ衣料の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Sports Clothing Revenue, means the sales value of Sports Clothing This report studies sales (consumption) of Sports Clothing in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, p …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DATA8102365 )"グリクラジドの中国市場" (英文:Investigation Report on China's Gliclazide Market, 2018-2022)はChina Research and Intelligence社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。